Neuroprotective effects of inhibitors of dipeptidyl peptidase-iV in vitro and in vivo.
Wu
Yong-Qian
YQ
Guilford Pharmaceuticals, Inc., Tributary St., Baltimore, MD, USA.
Limburg
David C
DC
Wilkinson
Douglas E
DE
Jackson
Paul
P
Steiner
Joseph P
JP
Hamilton
Gregory S
GS
Belyakov
Sergei A
SA
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D051379:Mice; D009046:Motor Neurons / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000494:pharmacology*
D018696:Neuroprotective Agents; D011480:Protease Inhibitors; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D018819:Dipeptidyl Peptidase 4